Open in interactive viewer → charts, metric popovers & call review

Sleep Number's High-Wire Act: Product Reset Meets Covenant Relief

A 99% stock drawdown frames a Q1 defined by a new product lineup, lender forbearance, and a $235M cost-saving plan.
SNBR · Earnings Call · 2026-05-12
When Sleep Number's stock closed on February 6, 2026, it was still a company with a future. By late June, the tape showed a catastrophic 98.9% collapse over just 90 days—a drawdown that erased virtually all market value. On May 12, when management reported Q1, the numbers told a story of a company fighting for survival on multiple fronts: a new product launch, a marketing reset, and a capital structure that required emergency lender intervention.

A Capital Structure in Crisis

The most immediate development was the credit agreement amendment, which management framed as life support. “On April 27, we reached an agreement with our existing lenders that provides near-term relief from certain financial covenants, adding $55 million of incremental liquidity, including a new $25 million term loan.” — Linda Findley, Executive (likely CEO or CFO) · 2026-05-12 The term loan, due June 30, 2026, is a stark reminder that this relief is just a bridge. Amy O'Keefe, the CFO, was candid about the timeline: “Yes, that's the expectation here. The short maturities ... we've been working towards this goal for months and months, and so we hired advisers, and we've been working in parallel ... our lenders are going to hold us accountable for that.” — Amy O'Keefe, Executive (likely CFO) · 2026-05-12 The company's net cash position sits at negative $458 million, and with a market cap of just $37 million, the recapitalization is existential, not optional. The liquidity math is equally tight. Total liquidity at quarter-end was $40 million, but that was before the amendment added $55 million. Management explicitly declined to provide full-year guidance, citing the ongoing strategic review. “We manage liquidity very, very tightly. And as we expect, collections to ramp over the Memorial Day holiday, which is consistent with our plan.” — Amy O'Keefe, Executive (likely CFO) · 2026-05-12 That holiday is the company's biggest sales window, and the Memorial Day selling season is now make-or-break.

The Product Reset and Early Signals

Amid the financial brinkmanship, the core business showed glimmers of life. The Comfort mode bed, launched in January as the entry point to a refreshed line, has delivered measurable improvements. Management highlighted a 15-point Net Promoter Score gain and, importantly, a 100 basis point reduction in return rates. The full new lineup hit stores on March 23, and the early data is encouraging: “During the launch period, stores set with the new lineup saw 12% higher ARU than stores with previous products.” — Linda Findley, Executive (likely CEO or CFO) · 2026-05-12 Average revenue per unit reached $6,021 in Q1, up slightly year-over-year, and management expects continued expansion as the mix shifts toward premium beds like the ComfortNext Lux. The gross margin story is more nuanced. Q1 margin was 57.9%, down 329 basis points year-over-year, but most of that was mix shift and legacy inventory discounting. Amy pointed to the underlying improvement: “The best part of that for me is the gross margin ... it's a 10 percentage point gross margin improvement compared to the prior year.” — Amy O'Keefe, CFO · 2026-03-12 That quote, from the March 2026 call, captures the thesis: the new beds are structurally more profitable, even before the full line reaches steady state. On the cost side, management has identified $235 million in annualized savings since early 2025, with $200 million already executed. The remaining $50 million is fixed-cost reductions, and the turnaround plan relies on those savings to offset ongoing revenue softness. Q1 operating loss widened to -$50 million, but free cash flow was a use of only $13.2 million, $20 million better than plan.

The Long Road Ahead

What makes this story compelling is the alignment—or misalignment—of the narrative. Management is executing a disciplined product and cost reset, and early consumer response is positive. Yet the balance sheet casts a long shadow. The Expense reductions are simply not enough to offset a 19% revenue decline in Q1, and the Q2 guidance of low-single-digit to flat sales growth assumes Memorial Day delivers a demand inflection. Linda Findley, reflecting on her first year as CEO, acknowledged the scope of the task:

When I joined Sleep Number, I saw a powerful brand, a compelling mission and a deeply committed team. I also saw a cost structure, product offering, marketing approach and balance sheet that limited long-term performance.

Linda Findley, Executive (likely CEO or CFO) · 2026-05-12
That candor is refreshing, but the market has already priced in a worst-case scenario. The stock now trades at a fraction of revenue—price-to-revenue of 0.03x—and the only path forward is a successful recapitalization that preserves the turnaround's momentum. The next few months will be pivotal. The term loan matures June 30, the Memorial Day weekend is the first real test of the new product line, and the lender negotiations will determine whether this is a restructuring or a renaissance. For now, Sleep Number is a high-wire act where every operational improvement is shadowed by the capital structure question.